Publication hits new high in “Frontiers in Microbiology”

Couple of my (research group) publications in Front. Microbiol. hits new heights with 10,000 views. Both the articles (1 research and 1 review) deals with bacteriophages and phage therapy. Here are the links,

  1. Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter Species. https://www.frontiersin.org/articles/10.3389/fmicb.2019.00574/full
  2. Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics? https://www.frontiersin.org/articles/10.3389/fmicb.2020.01434/full
FDA approves the use of phage therapy for COVID-19 patients. Here is our publication that deals with bacteriophages as alternatives to antibiotics.
Unknown's avatar

Published by Dr. Prasanth Manohar, Ph.D.,

Early career researcher in the field of Microbiology. Phage biologist, Author, Editor and Scientific writer. Expertise is in bacteriophage biology & genetics, Phage Therapy, ssRNA phages, Phage lysis systems, Single-cell analysis, protein antibiotics, and Antibiotic Resistance.